1st Quarter - Report — MAYO CLINIC for MAYO CLINIC (2021)

Firm

MAYO CLINIC

Client

MAYO CLINIC

Income

—

Expenses

$180,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

Reimbursement and coverage issues related to VA health care and Tricare

Lobbyist	Covered position, as disclosed
ANNE ROHALL-ANDRADE New	—

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Pharmacy PHA

Drug shortages;

Lobbyist	Covered position, as disclosed
ANNE ROHALL-ANDRADE New	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Medical/Disease Research/Clinical Labs MED

Support of clinical trials and research related to COVID-19; laboratory medicine

Lobbyist	Covered position, as disclosed
ANNE ROHALL-ANDRADE New	—

Contacted: SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Science/Technology SCI

Telemedicine technology; New diagnostic tests, Precision medicine; Broadband expansion and Internet access; Privacy and data security and usage

Lobbyist	Covered position, as disclosed
ANNE ROHALL-ANDRADE New	—

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; Disbursements from and repayments to the Provider Relief Fund; H.R. 1319 American Rescue Plan Act

Lobbyist	Covered position, as disclosed
ANNE ROHALL-ANDRADE New	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1319 (117th)

Medicare/Medicaid MMM

Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality and Transparency; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 1319 American Rescue Plan Act

Lobbyist	Covered position, as disclosed
ANNE ROHALL-ANDRADE New	—

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)